Cargando…
In silico validation of RNA-Seq results can identify gene fusions with oncogenic potential in glioblastoma
RNA-Sequencing (RNA-Seq) can identify gene fusions in tumors, but not all these fusions have functional consequences. Using multiple data bases, we have performed an in silico analysis of fusions detected by RNA-Seq in tumor samples from 139 newly diagnosed glioblastoma patients to identify in-frame...
Autores principales: | Hernandez, Ainhoa, Muñoz-Mármol, Ana Maria, Esteve-Codina, Anna, Alameda, Francesc, Carrato, Cristina, Pineda, Estela, Arpí-Lluciá, Oriol, Martinez-García, Maria, Mallo, Mar, Gut, Marta, del Barco, Sonia, Gallego, Oscar, Dabad, Marc, Mesia, Carlos, Bellosillo, Beatriz, Domenech, Marta, Vidal, Noemí, Aldecoa, Iban, de la Iglesia, Nuria, Balana, Carmen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9402576/ https://www.ncbi.nlm.nih.gov/pubmed/36002559 http://dx.doi.org/10.1038/s41598-022-18608-8 |
Ejemplares similares
-
A Comparison of RNA-Seq Results from Paired Formalin-Fixed Paraffin-Embedded and Fresh-Frozen Glioblastoma Tissue Samples
por: Esteve-Codina, Anna, et al.
Publicado: (2017) -
Gal-1 Expression Analysis in the GLIOCAT Multicenter Study: Role as a Prognostic Factor and an Immune-Suppressive Biomarker
por: Martínez-Bosch, Neus, et al.
Publicado: (2023) -
Glioblastoma: Relationship between Metabolism and Immunosuppressive Microenvironment
por: Hernández, Ainhoa, et al.
Publicado: (2021) -
Pseudoprogression as an adverse event of glioblastoma therapy
por: Balaña, Carmen, et al.
Publicado: (2017) -
Recurrent Glioblastoma: Ongoing Clinical Challenges and Future Prospects
por: Pineda, Estela, et al.
Publicado: (2023)